Expanding clinical trial access to include historically underrepresented ethnic and racial minorities means addressing root-cause barriers, including taxation.
Linda McCarty, JD, LLM
Advertisement
Articles by Linda McCarty, JD, LLM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Medidata, BioRender Announce New AI Partnerships Expanding Capabilities in Life Sciences
2
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
3
Rethinking Trial Access in Lower-Income Regions Through Patient-Centric, AI-Driven Models
4
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
